The leading industrial biotechnology event of the year took place in Brussels
The European Forum for Industrial Biotechnology and the Biobased Economy (EFIB) opened to a record delegation in Brussels at The Square. Now in its 6th year, EFIB successfully made the transformation from a small specialised conference to a market leading, pan European flagship event for the vibrant and dynamic sector of Europe's bioeconomy.
The event took place during the first ever European Biotech Week, and had 700 delegates in attendance all on site to gain access to the market place of 45 exhibitors and 20 technology showcase presentations. They took place alongside a formidable programme of senior leaders including Belgian Ministers, a record number of European policy makers and CEOs from Galactic, Ecover and several other multinational companies.
Read more about EFIB's record year
Read the full review on what happened at EFIB 2013
Join us next year in Reims, France for EFIB 2014
Dates for your Diary... 30 September - 2 October 2014 in Reims, Champagne-Ardenne France.
Join us in 2014 for an insight into this exciting and rapidly evolving landscape and be part of the process of building a stronger more sustainable biobased economy. Registration for EFIB 2014 is now open, book your place at the Super Early Bird rate.
Taking place, in association with IAR, EuropaBio and Smithers Rapra will build on the success of EFIB 2013, making the most of the event's new format to draw an even larger crowd of biobased economy professionals. Read more on what you can expect here
New to the bioeconomy? Want to find out more about the industry?
If you registered to attend EFIB, you will have gain exclusive online access to our new white paper, written by biotechnology industry expert Dr Dirk Carrez. "Entering the Bioeconomy: The 7 fundamentals of industrial biotechnology and the biobased economy" is the definitive field guide to the most important issues in the sector enabling you to get maximum benefit after your visit.
Global Partnerships and Alliances Key to Industrial Biotechnology Futures
Key drivers behind new partnerships and alliances in industrial biotechnology will be the need to access raw materials and technology at the required cost and amount and exposure to diversified markets, according to new forecasts by Smithers Rapra.
The Future of Alliances and Partnerships in Industrial Biotechnology to 2023 contains details of the competitive biotechnology landscape and quantitative forecasts until 2023, as well as details of emerging markets. It includes extensive primary research, and reveals what will be essential for the dynamic biotechnology industry in years to come.
Read more here
Keep up with the conversation and follow us on LinkedIn and Twitter
|In association with: |